DC Chemicals

DC67601 · Updated 28 October 2026

Sanofi Lipid 15

Product Datasheet

Sanofi Lipid 15 is an ionizable lipid investigated in CD8-targeted mRNA-LNPs for transient in vivo CAR-T-cell generation. Published studies report human T-cell transfection, CD22-directed tumor-cell killing, repeat dosing and tumor-burden reduction in humanized mice.

CAS No.3024023-96-6
Chemical NameSanofi Lipid 15
SynonymsSanofi Lipid-15, Lipid15, Lipid 15
SMILESCCCCCCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCCC)N(CCCN(C)C)C(=O)CCC(=O)OC(CCC)CCCCCC
FormulaC58H108O7N2
M.Wt945.51
Purity>95% by ELSD-HPLC
StoragePure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light.
Shipping conditionShips from Shanghai. Pure lipid is stable during ice-pack transport.
Publication
  1. Lemgart VT et al. Reprogramming CD22 CAR-T cells in vivo using CD8-targeted mRNA-LNPs to treat hematological malignancies. Molecular Therapy 34 (2026). DOI: 10.1016/j.ymthe.2026.02.020

Research evidence

Read detailed Formulation & Performance

Specifications are catalog specifications, not batch test results.